TEVA-THEOPHYLLINE SR 100 MG — DIN 02230085
THEOPHYLLINE : 100 MG · TEVA CANADA LIMITED · TABLET (EXTENDED-RELEASE) · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TEVA-THEOPHYLLINE SR?
TEVA-THEOPHYLLINE SR 100 MG contains THEOPHYLLINE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02230085, held by TEVA CANADA LIMITED, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 08-May-2018. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Theophylline cost around the world?
Theophylline is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 13 | 13 | SAR███.██ |
| Morocco | PPV (public price) | 5 | 10 | MAD███.██ |
| South Africa | single exit price | 5 | 8 | ZAR███.██ |
| Greece | producer price (ex-factory) | 7 | 7 | EUR███.██ |
| Iceland | max wholesale | 2 | 5 | ISK███.██ |
| Australia | ex-manufacturer | 4 | 4 | AUD███.██ |
| United States | acquisition | 1 | 2 | USD███.██ |
49 pack listings across 37 brand entries and 7 price bases, refreshed 08 Sep 2026. Ranges span every Theophylline pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Theophylline in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
20 holders have a Canadian DIN containing Theophylline, across 39 DINs, of which 6 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 5 | 5 | AA-THEO LA, THEO ER | Sourceable in Canada |
| LABORATOIRE ATLAS INC | 1 | 1 | ELIXIR DE THEOPHYLLINE | Sourceable in Canada |
| 3M PHARMACEUTICALS, A DIVISION OF 3M CANADA COMPANY | 6 | 0 | THEOLAIR SR TAB 200MG, THEOLAIR SR TAB 250MG, THEOLAIR SR TAB 300MG, THEOLAIR SR TAB 500MG, THEOLAIR TAB 125MG, +1 more | No marketed DIN |
| ASTRAZENECA CANADA INC | 4 | 0 | THEO-DUR 100 MG, THEO-DUR 200 MG, THEO-DUR 300 MG, THEO-DUR 450 MG | No marketed DIN |
| AVENTIS PHARMA INC 2905 Place Louis-R. Renaud Laval Quebec Canada H7V 0A3 | 3 | 0 | SLO-BID 100, SLO-BID 300, SLO-BID 50 | No marketed DIN |
| TEVA CANADA LIMITED | 3 | 0 | TEVA-THEOPHYLLINE SR | No marketed DIN |
| APOTEX INC | 2 | 0 | APO-THEO ER | No marketed DIN |
| ELVIUM LIFE SCIENCES | 2 | 0 | UNIPHYL | No marketed DIN |
| FOREST LABS INC | 2 | 0 | THEOPHYLLINE SUSTAINED RELEASE TAB 100MG, THEOPHYLLINE SUSTAINED RELEASE TAB 200MG | No marketed DIN |
| BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | 1 | 0 | QUIBRON T SR TAB 300MG | No marketed DIN |
| FOREST LABS INC 602 Harborside Financial Center, Plaza Three Jersey City New Jersey United States 07311 | 1 | 0 | THEOPHYLLINE SRT 300MG | No marketed DIN |
| THERAPEX DIVISION DE E-Z-EM CANADA INC | 1 | 0 | THEOPHYLLINE ELIXIR | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Theophylline |
|---|---|
| ATC code | R03DA04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02230085 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2230085 |
| Brand name | TEVA-THEOPHYLLINE SR |
| Generic / active ingredient | THEOPHYLLINE : 100 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | R03DA04 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R03DA |
| Current status | CANCELLED POST MARKET |
| Status date | 08-May-2018 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
6 of 39 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-THEO LA | 300 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 00692700 |
| AA-THEO LA | 200 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 00692697 |
| AA-THEO LA | 100 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 00692689 |
| ELIXIR DE THEOPHYLLINE | 80 MG / 15 ML | ELIXIR | LABORATOIRE ATLAS INC | MARKETED | 00627410 |
| THEO ER | 600 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 02360128 |
| THEO ER | 400 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 02360101 |
| APO-THEO ER | 400 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | APPROVED | 02358395 |
| APO-THEO ER | 600 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | APPROVED | 02358409 |
| PMS-THEOPHYLLINE ELIXIR | 80 MG / 15 ML | ELIXIR | PHARMASCIENCE INC | CANCELLED POST MARKET | 00575151 |
| PULMOPHYLLINE ELX | 80 MG / 15 ML | ELIXIR | LABORATOIRE RIVA INC. | DORMANT | 00466409 |
2 · Same class — other molecules in ATC R03DA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Theophylline | AA-THEO LA · APO-THEO ER · ELIXIR DE THEOPHYLLINE · PMS-THEOPHYLLINE ELIXIR · +27 more | 39 | 6 | Yes |
| Theophylline, Combinations Excl. Psycholeptics | BRONCHYL SYR · CHOLEDYL EXPECTORANT · I D M EXPECTORANT TAB · IDM TAB · +8 more | 12 | 1 | Yes |
| Aminophylline | AMINOPHYLLINE INJ 25MG/ML · AMINOPHYLLINE INJ 50MG/ML · AMINOPHYLLINE INJECTION 50MG/ML · AMINOPHYLLINE TAB 0.1GM · +4 more | 9 | 1 | Yes |
| Choline Theophyllinate | APO OXTRIPHYLLINE TAB 100MG · APO OXTRIPHYLLINE TAB 200MG · APO OXTRIPHYLLINE TAB 300MG · CHOLEDYL · +13 more | 17 | 0 | Not in Canada |
| Diprophylline | PROTOPHYLLINE ELIXIR 100MG · PROTOPHYLLINE INJ 500MG/2ML · PROTOPHYLLINE SOLUTION 100MG · PROTOPHYLLINE SUP 500MG ADULTES · +1 more | 5 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R03D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R03DC | Montelukast · Zafirlukast | 98 | 41 |
| R03DX | Benralizumab · Mepolizumab · Omalizumab · Reslizumab · Roflumilast · +1 more | 19 | 17 |
| R03DB | Theophylline And Adrenergics | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVA-THEOPHYLLINE SR called?
The same molecule, Theophylline, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Theo-Dur | Latin | Iceland |
| Alcophyllex | Latin | South Africa |
| MICROPHYLLINE | Latin | Morocco |
| XANTHIUM LP | Latin | Morocco |
| Nuelin Liquid | Latin | South Africa |
| THEOSTAT LP | Latin | Morocco |
| AVOLEN S.R TABLET | Latin | Saudi Arabia |
| Bronchoretard | Latin | Iceland |
| Nuelin | Latin | Australia |
| Nuelin SA | Latin | South Africa |
| THEOPHYLLINE BRUNEAU ADULTE | Latin | Morocco |
| THEOPHYLLINE BRUNEAU ENFANT | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.